Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples